Nobilis RT+IBmulti+G+ND
Active substance
ATC code
Species
Chickens (future breeders)
Indications
Active immunisation of breeder chickens for:
- reduction of infection and prevention of egg drop caused by the Massachusetts serotype of infectious bronchitis virus (IBV);
- reduction of egg drop and eggshell defects caused by the D274/D207 serotype of infectious bronchitis virus (IBV);
- reduction of infection caused by Newcastle disease virus (NDV);
- prevention of respiratory signs and reduction of egg drop and eggshell defects turkey rhinotracheitis (TRT) virus;
- passive immunisation of the progeny of the vaccinated birds against infectious bursal disease virus (IBDV).
Onset of immunity:
• IBV, NDV, ARTV: 4 weeks post-vaccination
• IBDV in progeny: 1 day of age
Duration of immunity:
• IBV, NDV, ARTV: one laying period.
• IBDV in progeny: 4 weeks of age.
Dose to be administered and administration route
The vaccine should be given tochickens around 14-20 weeks of age but not later than 4 weeks before the expected onset of lay.
If live vaccines were used to prime chickens against Infectious Bronchitis, Rhinotracheitis, Newcastle Disease and Infectious Bursal Disease, the vaccine should be given at least 4 weeks after the administration of the live vaccines. Administer one dose of 0.5 ml vaccine per chickens via intramuscular injection in the thigh or chest muscle.
Before using the vaccine allow it to reach ambient temperature (15 °C – 25 °C).
Shake the bottle vigorously before use and periodically during use.
Ensure that vaccination equipment is clean and sterile before use.
Do not use vaccination equipment with rubber parts as the excipient may damage certain types of rubber.
Adverse reactions
Chickens (future breeders):
| Very common (>1 animal / 10 animals treated): | Injection site swelling1 |
1 A mild swelling which may be observed for 2 weeks.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See section “Contact details” of the package leaflet.
TRUSTED SOURCE
